Badreddin Edris - 16 Jun 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/John R. Moore Attorney-in-Fact for Badreddin Edris
Issuer symbol
EWTX
Transactions as of
16 Jun 2025
Net transactions value
$0
Form type
4
Filing time
18 Jun 2025, 19:37:16 UTC
Previous filing
05 Mar 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Edris Badreddin Director C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER /s/John R. Moore Attorney-in-Fact for Badreddin Edris 18 Jun 2025 0001786966

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 16 Jun 2025 Common Stock 30,000 $14.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders.